| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net increase in cash and cash equivalents | 127,966 | - |
| Cash and cash equivalents at beginning of period | 3,758,232 | - |
| Net increase in cash and cash equivalents | - | 2,240,262 |
| Cash and cash equivalents at end of period | 3,886,198 | - |
IMMUCELL CORP DE (ICCC)
IMMUCELL CORP DE (ICCC)